Home/Database/AUNP-12
Immune SupportPre-clinical

AUNP-12

AUNP-12 synthetic PD-1-derived immune checkpoint peptide

N/A Amino Acids · MW: N/A

Amino Acids

N/A

Molecular Weight

N/A

Half-life

Unknown; likely short in circulation

Research Score

4.3

Studies

18

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is AUNP-12?

AUNP-12 is a synthetic peptide designed to interfere with the PD-1/PD-L1 immune checkpoint axis. It has been studied as an immuno-oncology tool to restore T-cell activity in preclinical models.

Key Benefits & Mechanisms

PD-1/PD-L1 blockade

T-cell reinvigoration

immune checkpoint research

tumor-immunity studies

Research Summary

Preclinical studies suggest AUNP-12 can reduce PD-1-mediated suppression and improve effector T-cell function in model systems. It remains a research-only checkpoint peptide with no established clinical dosing.